-transparent.png){kind=logo}
Two patients with renal failure developed N-acetylprocainamide toxicity while receiving procainamide. Treatment consisted of continuous arteriovenous hemofiltration in one and hemodialysis followed by continuous arteriovenous hemodiafiltration in the other. The efficacy of these treatments was compared with the efficacy of three-times-weekly hemodialysis as used in two patients on chronic hemodialysis who had elevated N-acetylprocainamide levels. Continuous methods produced a more rapid reduction in N-acetylprocainamide levels than intermittent hemodialysis.
Related Publications
D T Domoto, and
W W Brown, and
P Bruggensmith
January 1985,
Transactions - American Society for Artificial Internal Organs,
D T Domoto, and
W W Brown, and
P Bruggensmith
March 1995,
Critical care medicine,
D T Domoto, and
W W Brown, and
P Bruggensmith
May 1995,
The Journal of pediatrics,
D T Domoto, and
W W Brown, and
P Bruggensmith
May 1994,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
D T Domoto, and
W W Brown, and
P Bruggensmith
October 1991,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
D T Domoto, and
W W Brown, and
P Bruggensmith
September 1985,
Archives of internal medicine,
D T Domoto, and
W W Brown, and
P Bruggensmith
February 1991,
Tijdschrift voor kindergeneeskunde,
D T Domoto, and
W W Brown, and
P Bruggensmith
February 2008,
Therapeutic drug monitoring,
D T Domoto, and
W W Brown, and
P Bruggensmith
January 1984,
Critical care nurse,
D T Domoto, and
W W Brown, and
P Bruggensmith
July 1990,
The Medical clinics of North America,
